Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
PRIORITY PRESS - 52nd Annual Meeting and Exposition of the American Society of Hematology
Expanding Iron Chelation Applications: New Data on Organ Protection
Orlando, Florida / December 4-7, 2010
Orlando - The role of iron chelators, long employed in thalassemia, was supported in an expanding list of both malignant and non-malignant hematological diseases in a series of studies presented at ASH. The ability of iron chelators to...
MEDICAL FRONTIERS - 52nd Annual Meeting and Exposition of the American Society of Hematology
Greater Prophylaxis from Venous Thromboembolism for Cancer Patients
Orlando, Florida / December 4-7, 2010
Orlando - The more than twofold increase in rates of venous thromboembolism (VTE) in cancer patients over a recent 5-year period has identified a growing crisis in comprehensive care of patients with malignancy. The causes of the rising...
PRIORITY PRESS - 52nd Annual Meeting and Exposition of the American Society of Hematology
Validating the Subcutaneous Route in Multiple Myeloma Maintenance Therapy
Orlando, Florida / December 4-7, 2010
Orlando - New phase III data demonstrating that subcutaneous (s.c.) administration of a drug commonly administered intravenously (i.v.) is as effective but better tolerated in the treatment of multiple myeloma (MM) has been proposed as a...
PRIORITY PRESS - 52nd Annual Meeting and Exposition of the American Society of Hematology
Defining Disease Burden and Treatment Efficacy in Paroxysmal Nocturnal Hemoglobinuria
Orlando, Florida / December 4-7, 2010
Orlando - Paroxysmal nocturnal hemoglobinuria (PNH) confers a high risk of morbidity and mortality. In half of patients, the severe and persistent hemolysis that characterizes the disease leads to thromboses involving the liver and cerebral...
FRONTLINE - Hematology/Oncology
Evolving Standards of Therapy in Multiple Myeloma
June 2010
Reviewed and edited by: Kevin W
PRIORITY PRESS - 15th Congress of the European Hematology Association
Update on the Treatment of Iron Overload
Barcelona, Spain / June 10-13, 2010
Barcelona - Patients who become transfusion-dependent due to chronic anemia are highly predisposed to iron overload and iron overload in turn is toxic to many organs. Guidelines indicate that patients with high serum ferritin concentrations...
PRIORITY PRESS - 15th Congress of the European Hematology Association
Novel Agents Significantly Improve Outcomes in Multiple Myeloma
Barcelona, Spain / June 10-13, 2010
Barcelona - Novel agents, including a proteasome inhibitor and two immunomodulatory drugs, are changing the therapeutic landscape for multiple myeloma. Unlike in the past, the goal of treatment today is to attain complete remission....
PRIORITY PRESS - 36th Annual Meeting of the European Group for Blood and Bone Marrow Transplantation (EBMT)
New Antifungal Strategies in High-risk Stem Cell Transplant Recipients
Vienna, Austria / March 21-24, 2010
Vienna - Although Candida infection is still probably the most widespread fungal infection in a surgical setting, Aspergillus and other mold pathogens are a substantial cause of morbidity and mortality in immunosuppressed patients. In...
PRIORITY PRESS - 36th Annual Meeting of the European Group for Blood and Bone Marrow Transplantation (EBMT)
Progress in Infection Management of Allogeneic Stem Cell Recipients
Vienna, Austria / March 21-24, 2010
Vienna - In the last 10 years, widespread use of allogeneic hematopoietic stem cell transplantation has decreased the risk of recurrence in patients with aggressive hematological malignancies. However, the associated conditioning and...